Metsera - MTSR Total Company Value-to-Revenue Ratio

metsera.com (MTSR) - corporate logo

Metsera Inc is implementing eco-friendly storage methods for biological preparations, focusing on organic growth and clinical trials. This EV/Sales chart confirms the valuation trend relative to debt-free revenue, where the metric level stands at 0.00. This helps filter out speculative noise. The promising biotech firm is building a powerful scientific image in obesity therapy, earning the trust of major investors.

MTSR Metsera Inc: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/29/2025

metsera.com - analytical breakdowns and key metrics (MTSR)

- share price and expert price forecast:
Fundamental valuation:metsera.com (MTSR)
Manufactured product of Metsera Inc

Attracting elite biochemists and retaining key competencies in the development of obesity drugs create the foundation for the rapid scaling of Metsera Inc (MTSR). By analyzing the EV/Sales trend, an investor assesses the total enterprise value relative to revenue, which allows for the determination of the market premium for future growth and confirms the fundamental stability of the startup's quotes.

Competitor analysis

ASND: Enterprise Value-to-Revenue Ratio|MDGL: EV/Sales Multiple|CORT - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Rhythm Corp|Akero Corp (AKRO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio moonlaketx.com (MLTX)|Company Value to Revenue Crinetics Pharmaceuticals CRNX|Enterprise Value-to-Revenue Ratio NewAmsterdam Pharma N.V. NAMS|Total Company Value-to-Revenue Ratio Soleno Therapeutics Inc (SLNO)|FOLD - Enterprise Value-to-Revenue Ratio|ETNB: Enterprise Value-to-Revenue Ratio|AGIO: EV/Sales Multiple|Structure Therapeutics Inc. - Business Value to Revenue|MDXG (MiMedx Corp) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Rezolute Inc RZLT|EV/Sales Multiple LXRX|Total Company Value-to-Revenue Ratio MBX Corp|Altimmune Pharma - Company Value to Revenue|EV/Sales Multiple aardvarktherapeutics.com AARD|SGMT: Company Value to Revenue|Business Value to Revenue BIOA (BioAge Labs)|BMEA: EV/Sales Multiple|QNCX: Enterprise Value-to-Revenue Coefficient|GUTS (Fractyl Health, Inc.) - EV/Sales Multiple|EV/Sales Multiple vtvtherapeutics.com|Company Value to Revenue ATPC (Agape ATP Corp)|Total Company Value-to-Revenue Ratio Pluristem Therapeutics|Enterprise Value-to-Revenue Ratio synlogictx.com SYBX|LPCN: Company Value to Revenue Ratio|MTNB - Enterprise Value-to-Revenue Ratio|Spruce Biosciences, Inc. (SPRB) - Company Value to Revenue|GLTO: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - EV/Sales Multiple|Organovo Corp (ONVO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Radius Recycling (RDUS)